Typicality: | 0.588 |
Saliency: | 0.412 |
for 30 days | 9 | temporal |
in one study | 6 | location |
to receive standard curcumin | 6 | purpose |
subject → be randomized to → placebo | 39 |
subject → be randomized to receive → placebo | 13 |
subject → be randomised to receive → placebo | 7 |
subject → randomize to → placebo | 6 |
subject → be randomized into → placebo groups | 3 |
subject → be randomised to → placebo | 3 |
negative | neutral | positive |
0.116 | 0.830 | 0.054 |
Raw frequency | 71 |
Normalized frequency | 0.412 |
Modifier score | 1.000 |
Perplexity | 56.922 |